In addition, the administration said it is allowing an early phase clinical study of a derivative of ibogaine to move forward.
FDA moves to fast-track review of three psychedelic drug studies
Welcome to LJ News Opinions, where breaking news stories have captivated us for over 20 years.
Join us in this journey of sharing points of view about the news – read, react, engage, and unleash your opinion!